Skip to main content

Table 2 Comparison of pregnancy characteristics and delivery outcomes of the study population between four groups

From: The impact of gestational weeks of Coronavirus disease 2019 (COVID-19) infection on perinatal outcomes

Variables

Group1 (N = 175)

Group2 (N = 176)

Group3 (N = 200)

Group 4 (N = 60)

F/χ2

P

Gestational age at infection (weeks)

24.2 ± 2

33.4 ± 2.4

38.5 ± 0.8

40.3 ± 0.3

2519.91

< 0.001

Gestational age at delivery (weeks)

39.2 ± 1.2

38.6 ± 1.8

39.1 ± 0.8

40.5 ± 0.4

33.48

< 0.001

Fever (n, %)

150 (85.7)

158 (89.8)

111 (55.5)

16 (26.7)

101.89

< 0.001

GDM (n, %)

39 (22.3)

32 (18.2)

29 (14.5)

5 (8.3)

7.50

0.006

Pre-eclampsia (n, %)

28 (16)

23 (13.1)

15 (7.5)

4 (6.7)

7.92

0.005

PROM (n, %)

31 (17.7)

40 (22.7)

42 (21.0)

6 (10.0)

0.30

0.583

Vaginal delivery (n, %)

117 (66.9)

155 (88.1)

140 (70)

47 (78.3)

0.60

0.439

  1. GDM: gestational diabetes mellitus; PROM: Premature rupture of membranes; data are expressed as mean ± SD or n (%); P < 0.05, considered statistically significant. Group 1 participants were infected with COVID-19 during 14–27+6 weeks gestation; Group 2 participants were infected with COVID-19 during 28–36+6 weeks gestation; Group 3 participants were infected with COVID-19 during 37–39+6 weeks gestation; Group 4 participants COVID-19 infection with gestational weeks ≥ 40 weeks